Germ cell defects and hematopoietic hypersensitivity to gamma- interferon in mice with a targeted disruption of the Fanconi anemia C gene

Fanconi anemia (FA) is an autosomal recessive chromosome instability syndrome characterized by progressive bone marrow (BM) failure, skeletal defects, and increased susceptibility to malignancy. FA cells are hypersensitive to DNA cross-linking agents, oxygen and have cell cycle abnormalities. To develop an animal model of the disease we generated mice homozygous for a targeted deletion of exon 9 of the murine FA complementation group C gene (fac). Mutant mice had normal neonatal viability and gross morphology, but their cells had the expected chromosome breakage and DNA cross-linker sensitivity. Surprisingly, male and female mutant mice had reduced numbers of germ cells and females had markedly impaired fertility. No anemia was detectable in the peripheral blood during the first year of life, but the colony forming capacity of marrow progenitor cells was abnormal in vitro in mutant mice. Progenitor cells from fac knock-out mice were hypersensitive to interferon gamma. This previously unrecognized phenotype may form the basis for BM failure in human FA.

[1]  A. D’Andrea,et al.  Clinical variability of Fanconi anemia (type C) results from expression of an amino terminal truncated Fanconi anemia complementation group C polypeptide with partial activity. , 1996, Blood.

[2]  M. Buchwald Complementation groups: one or more per gene? , 1995, Nature Genetics.

[3]  S. Naylor,et al.  Microcell mediated chromosome transfer maps the Fanconi anaemia group D gene to chromosome 3p , 1995, Nature Genetics.

[4]  Jian Yu,et al.  Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis , 1995, Cell.

[5]  N. Young,et al.  Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. , 1995, Blood.

[6]  B. Mach,et al.  Identification of Cytosolic Proteins That Bind to the Fanconi Anemia Complementation Group C Polypeptide in Vitro , 1995, The Journal of Biological Chemistry.

[7]  B. Alter Hematologic abnormalities in Fanconi anemia. , 1995, Blood.

[8]  N. Copeland,et al.  DNA rearrangements located over 100 kb 5' of the Steel (Sl)-coding region in Steel-panda and Steel-contrasted mice deregulate Sl expression and cause female sterility by disrupting ovarian follicle development. , 1995, Genes & development.

[9]  D. Lipschitz,et al.  Interferon‐γ exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development , 1995 .

[10]  M. Buchwald,et al.  Fanconi anemia and novel strategies for therapy. , 1994, Blood.

[11]  R. Samulski,et al.  Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. , 1994, The Journal of clinical investigation.

[12]  H. Youssoufian Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Heinrich,et al.  Repression of Fanconi anemia gene (FACC) expression inhibits growth of hematopoietic progenitor cells. , 1994, The Journal of clinical investigation.

[14]  M. Buchwald,et al.  A functionally active retrovirus vector for gene therapy in Fanconi anemia group C , 1994 .

[15]  A. D’Andrea,et al.  The Fanconi anemia polypeptide FACC is localized to the cytoplasm. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[16]  T. Visakorpi,et al.  Automated peak detection and cell cycle analysis of flow cytometric DNA histograms. , 1994, Cytometry.

[17]  B. Alter,et al.  Brain tumors in patients with Fanconi's anemia. , 1994, Archives of pediatrics & adolescent medicine.

[18]  C. Mathew,et al.  Mutation analysis of the Fanconi anemia gene FACC. , 1994, American journal of human genetics.

[19]  R. Moses,et al.  Hypersensitivity to oxygen is a uniform and secondary defect in Fanconi anemia cells. , 1993, Mutation research.

[20]  M. Pesce,et al.  Stem cell factor and leukemia inhibitory factor promote primordial germ cell survival by suppressing programmed cell death (apoptosis). , 1993, Development.

[21]  C. Mathew,et al.  A nonsense mutation and exon skipping in the Fanconi anaemia group C gene. , 1993, Human molecular genetics.

[22]  R. Gibson,et al.  A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews , 1993, Nature Genetics.

[23]  M. Buchwald,et al.  Cloning and analysis of the murine Fanconi anemia group C cDNA. , 1993, Human molecular genetics.

[24]  M. Buchwald,et al.  A Leu554-to-Pro substitution completely abolishes the functional complementing activity of the Fanconi anemia (FACC) protein. , 1993, Human molecular genetics.

[25]  R. Heim,et al.  Heterozygous manifestations in four autosomal recessive human cancer-prone syndromes: ataxia telangiectasia, xeroderma pigmentosum, Fanconi anemia, and Bloom syndrome. , 1992, Mutation research.

[26]  M. Buchwald,et al.  Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9 , 1992, Nature Genetics.

[27]  B. Alter Fanconi's Anemia: Current Concepts , 1992 .

[28]  W. R. Shannon,et al.  Cloning of cDNAs for Fanconi's anaemia by functional complementation , 1992, Nature.

[29]  A. Bradley,et al.  Genomic DNA microextraction: a method to screen numerous samples. , 1992, Analytical biochemistry.

[30]  B. Alter,et al.  Erythropoiesis in Fanconi's anemia , 1991 .

[31]  Allan Bradley,et al.  Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice , 1991, Cell.

[32]  A. Rogatko,et al.  International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. , 1989, Blood.

[33]  H. Hoehn,et al.  Fanconi anemia mutation causes cellular susceptibility to ambient oxygen. , 1988, American journal of human genetics.

[34]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[35]  J. Gitschier,et al.  An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences. Application to hemophilia A. , 1987, The New England journal of medicine.

[36]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[37]  M. Sasaki Is Fanconi's anaemia defective in a process essential to the repair of DNA cross links? , 1975, Nature.

[38]  G. Fanconi Familial constitutional panmyelocytopathy, Fanconi's anemia (F.A.). I. Clinical aspects. , 1967, Seminars in hematology.

[39]  K. Mullis,et al.  Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. , 1987, Methods in enzymology.

[40]  M. Buchwald,et al.  Identification of two complementation groups in Fanconi anemia , 1985, Somatic cell and molecular genetics.

[41]  N. Young,et al.  Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[42]  M. Cohen,et al.  The cytogenetic response of Fanconi's anemia lymphoblastoid cell lines to various clastogens. , 1982, Cytogenetics and cell genetics.